Intramuscular HPV Vaccination Market Overview
The Intramuscular HPV Vaccination Market was valued at USD 6.6 billion in 2024 and is projected to reach USD 12.0 billion by 2035, growing at a CAGR of 5.6%. This market focuses on vaccines administered via intramuscular injection to prevent human papillomavirus infections, which are linked to cervical cancer and other malignancies. The market targets three primary populations: adolescents,...
0 Commentaires 0 Parts 5 Vue 0 Aperçu